• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌腹膜转移模型中适应性免疫的改变

Alteration of Adaptive Immunity in a Colorectal Peritoneal Carcinomatosis Model.

作者信息

Shi Rongchen, Xiang Wei, Kang Xia, Zhang Lili, Wang Jinping, Miao Hongming, He Fengtian

机构信息

Department of Biochemistry and Molecular Biology, Third Military Medical University (Army Medical University), Chongqing 400038, China.

Department of Military Psychology, School of Psychology, Third Military Medical University (Army Medical University), Chongqing 400038, China.

出版信息

J Cancer. 2019 Jan 1;10(2):367-377. doi: 10.7150/jca.27947. eCollection 2019.

DOI:10.7150/jca.27947
PMID:30719130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6360308/
Abstract

Colorectal cancer (CRC) usually gives rise to transcoelomic spread and ultimately causes peritoneal carcinomatosis (PC). However, mechanism studies, especially the immunological basis of colorectal PC, are rarely revealed due to lack of a suitable PC model. Here we selected a mouse colorectal cancer cell line MC-38 for intraperitoneal inoculation in the C57BL/6 mice to mimic the development of colorectal PC. We demonstrated that the injected CRC cells preferentially and rapidly migrated and colonized in the visceral fat tissues, but not in other visceral organs. With flow cytometric analysis, we found the proportions of spleen T cells and B cells were not affected by PC progression, while the ratios of blood CD4+ and CD8+ T cells were largely influenced. Especially, the quantity or activity of CD4+ and CD8+ T cells in visceral fats were intimately regulated by PC development. Taken together, we successfully constructed a colorectal PC model in immune-competent mice and revealed the alteration of adaptive immunity in PC development. Our study might potentiate the research and therapy strategies of colorectal PC.

摘要

结直肠癌(CRC)通常会引发经体腔播散,最终导致腹膜癌病(PC)。然而,由于缺乏合适的PC模型,机制研究,尤其是结直肠癌PC的免疫基础研究很少被揭示。在这里,我们选择了一种小鼠结肠癌细胞系MC-38,将其腹腔接种到C57BL/6小鼠体内,以模拟结直肠癌PC的发展。我们证明,注射的CRC细胞优先且迅速地迁移并定植在内脏脂肪组织中,而不是其他内脏器官中。通过流式细胞术分析,我们发现脾脏T细胞和B细胞的比例不受PC进展的影响,而血液中CD4+和CD8+ T细胞的比例受到很大影响。特别是,内脏脂肪中CD4+和CD8+ T细胞的数量或活性受到PC发展的密切调节。综上所述,我们在免疫健全的小鼠中成功构建了结直肠癌PC模型,并揭示了PC发展过程中适应性免疫的改变。我们的研究可能会加强结直肠癌PC的研究和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/37d90d00a1f4/jcav10p0367g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/1027b1c27ea1/jcav10p0367g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/b47fae2dec3f/jcav10p0367g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/f4c99c432ffd/jcav10p0367g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/6f1fd311073c/jcav10p0367g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/87a745c77ab1/jcav10p0367g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/6d0f0c234c49/jcav10p0367g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/f9bf148acac6/jcav10p0367g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/37d90d00a1f4/jcav10p0367g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/1027b1c27ea1/jcav10p0367g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/b47fae2dec3f/jcav10p0367g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/f4c99c432ffd/jcav10p0367g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/6f1fd311073c/jcav10p0367g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/87a745c77ab1/jcav10p0367g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/6d0f0c234c49/jcav10p0367g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/f9bf148acac6/jcav10p0367g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e0/6360308/37d90d00a1f4/jcav10p0367g008.jpg

相似文献

1
Alteration of Adaptive Immunity in a Colorectal Peritoneal Carcinomatosis Model.结直肠癌腹膜转移模型中适应性免疫的改变
J Cancer. 2019 Jan 1;10(2):367-377. doi: 10.7150/jca.27947. eCollection 2019.
2
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum.结直肠腹膜癌病的病理生理学:腹膜的作用。
World J Gastroenterol. 2016 Sep 14;22(34):7692-707. doi: 10.3748/wjg.v22.i34.7692.
3
Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.结直肠癌源性腹膜癌转移:发病率及当前治疗策略
Ann Surg. 2006 Feb;243(2):212-22. doi: 10.1097/01.sla.0000197702.46394.16.
4
Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer.结缔组织生长因子可作为结直肠癌腹膜转移的治疗剂和预测因子。
Clin Cancer Res. 2011 May 15;17(10):3077-88. doi: 10.1158/1078-0432.CCR-09-3256. Epub 2011 May 10.
5
Peritoneal carcinomatosis from colorectal cancer: HIPEC?结直肠癌腹膜转移癌:热灌注化疗(HIPEC)?
Surg Oncol. 2007 Dec;16 Suppl 1:S149-52. doi: 10.1016/j.suronc.2007.10.026.
6
Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.意外腹膜癌病是否仍然是结直肠肝转移切除的禁忌症?术中发现结直肠肝转移合并腹膜种植时的联合切除术。
Eur J Surg Oncol. 2013 Sep;39(9):981-7. doi: 10.1016/j.ejso.2013.06.009. Epub 2013 Jul 8.
7
Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases.源于直肠或结肠腺癌的腹膜癌病经细胞减灭术(CRS)联合腹腔热灌注化疗(HIPEC)治疗:两种不同的疾病。
Clin Transl Oncol. 2018 Oct;20(10):1268-1273. doi: 10.1007/s12094-018-1857-9. Epub 2018 Apr 17.
8
Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在结直肠腹膜转移癌中的准确性:评估化疗反应的潜在工具
Anticancer Res. 2017 Feb;37(2):929-934. doi: 10.21873/anticanres.11401.
9
Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A pilot study.结直肠癌腹膜转移癌:确定减瘤手术及腹腔热灌注化疗成功的预测因素——一项初步研究
J Egypt Natl Canc Inst. 2018 Dec;30(4):143-150. doi: 10.1016/j.jnci.2018.10.004. Epub 2018 Nov 22.
10
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.荷兰结直肠源性同步腹膜癌转移的细胞减灭术及腹腔内热灌注化疗的治疗趋势
Eur J Surg Oncol. 2015 Apr;41(4):466-71. doi: 10.1016/j.ejso.2015.01.018. Epub 2015 Jan 29.

引用本文的文献

1
5-aza-2'-deoxycytidine potentiates anti-tumor immunity in colorectal peritoneal metastasis by modulating ABC A9-mediated cholesterol accumulation in macrophages.5-氮杂-2'-脱氧胞苷通过调节 ABCA9 介导的巨噬细胞胆固醇积累增强结直肠腹膜转移的抗肿瘤免疫。
Theranostics. 2022 Jan 1;12(2):875-890. doi: 10.7150/thno.66420. eCollection 2022.
2
Dietary fats suppress the peritoneal seeding of colorectal cancer cells through the TLR4/Cxcl10 axis in adipose tissue macrophages.膳食脂肪通过脂肪组织巨噬细胞中的 TLR4/Cxcl10 轴抑制结直肠癌细胞的腹膜种植。
Signal Transduct Target Ther. 2020 Oct 15;5(1):239. doi: 10.1038/s41392-020-00327-z.

本文引用的文献

1
Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression.单酰甘油脂肪酶调节大麻素受体 2 依赖性巨噬细胞激活和癌症进展。
Nat Commun. 2018 Jul 3;9(1):2574. doi: 10.1038/s41467-018-04999-8.
2
CAR T cell immunotherapy for human cancer.嵌合抗原受体 T 细胞免疫疗法治疗人类癌症。
Science. 2018 Mar 23;359(6382):1361-1365. doi: 10.1126/science.aar6711.
3
Cancer immunotherapy using checkpoint blockade.使用免疫检查点阻断的癌症免疫疗法。
Science. 2018 Mar 23;359(6382):1350-1355. doi: 10.1126/science.aar4060. Epub 2018 Mar 22.
4
Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells.核心岩藻糖基化的阻断降低PD-1的细胞表面表达并促进T细胞的抗肿瘤免疫反应。
Cell Rep. 2017 Aug 1;20(5):1017-1028. doi: 10.1016/j.celrep.2017.07.027.
5
Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model.在小鼠结直肠癌转移模型中,用VEGF(R)抑制剂进行预处理可降低组织间液压力,增加腹腔内化疗药物的渗透,并抑制肿瘤生长。
Oncotarget. 2015 Oct 6;6(30):29889-900. doi: 10.18632/oncotarget.5092.
6
Improving Anti-Tumor Activity of Curcumin by Polymeric Micelles in Thermosensitive Hydrogel System in Colorectal Peritoneal Carcinomatosis Model.在结直肠癌腹膜转移模型中,通过热敏水凝胶系统中的聚合物胶束提高姜黄素的抗肿瘤活性。
J Biomed Nanotechnol. 2015 Jul;11(7):1173-82. doi: 10.1166/jbn.2015.2073.
7
The future of immune checkpoint therapy.免疫检查点疗法的未来。
Science. 2015 Apr 3;348(6230):56-61. doi: 10.1126/science.aaa8172.
8
Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview.结直肠来源的腹膜转移瘤经细胞减灭术和 HIPEC 治疗:综述。
World J Gastrointest Oncol. 2014 Oct 15;6(10):407-12. doi: 10.4251/wjgo.v6.i10.407.
9
Colorectal cancer statistics, 2014.结直肠癌统计数据,2014 年。
CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17. doi: 10.3322/caac.21220. Epub 2014 Mar 17.
10
Colorectal cancer.结直肠癌。
Lancet. 2014 Apr 26;383(9927):1490-1502. doi: 10.1016/S0140-6736(13)61649-9. Epub 2013 Nov 11.